Abstract
目的：对比眼动脉逆行和顺行介入治疗CRAO的疗效。方法：平均发病时间22h的CRAO者50只眼，分为眼动脉逆行介入组26眼，眼动脉顺行介入组24眼，均在DSA下采用尿激酶40万U、罂粟碱30mg进行溶栓治疗，最后从DSA，FFA，视力的改变进行分析。结果：逆行、顺行治疗后均见眼动脉及其分支增粗循环加快和眼环显著，FFA有效率相似，视力改善相似，在介入及随访过程中均无全身、眼部合并症。结论：眼动脉逆行和顺行介入溶栓治疗CRAO均可取得较好的疗效，逆行安全性高。 Objective: To evaluate the clinical efficiency of retrograde as a novel method and interventional therapy for central retinal artery occlusion (CRAO). Method: CRAO 50 eyes with average onset time of 22 h, were divided into ophthalmic artery retrograde group with 26 eyes, ophthalmic artery intervention group with 24 eyes. All eyes were used urokinase 400000U, papaverine 30 mg under DSA for thrombolysis treatment, and then DSA, FFA, vision changes were analyzed. Results: Retrograde and intervention treatment were found enlargement of ophthalmic artery and its branches, and eye ring accelerated circularly. FFA showed the efficient change and vision im-provement are similar in both groups, and there are no body and eye complications occurred in the process of intervention and follow-up. Conclusion: Ophthalmic artery retrograde and interventional thrombolysis therapy for CRAO can obtain same effect, and the former as a developed novel ophthalmic artery retrograde intervention method showed high safety.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
